Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-21-128430
Filing Date
2021-10-21
Accepted
2021-10-21 15:40:03
Documents
1
Period of Report
2021-10-21

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2130788-1_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2130788-1_4seq1.xml 4 3270
  Complete submission text file 0001104659-21-128430.txt   4954
Mailing Address C/O TENAX THERAPEUTICS, INC. ONE COPLEY PARKWAY, SUITE 490 MORRISVILLE NC 27560
Business Address
RALLIS CHRIS A (Reporting) CIK: 0001185945 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-32295 | Film No.: 211336951

Mailing Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709
Business Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709 (919) 636-4530
FENNEC PHARMACEUTICALS INC. (Issuer) CIK: 0001211583 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)